Notice No20210517-4Notice Date17 May 2021
SubjectRevised Settlement Schedule Offer to Buy – Acquisition Window (Buyback) for AARTI DRUGS LTD.

Subject: Revised Settlement Schedule Offer to Buy – Acquisition Window (Buyback) for AARTI DRUGS LTD.


With reference to Notice No.20210426-2 dated April 26, 2021, revised settlement calendar pertaining to Offer to Buy – Acquisition Window (Buyback) AARTI DRUGS LTD. was conducted from 27/04/2021 to 10/05/2021will be as under:


Settlement Type

Settlement No.

Bid Start Date

Bid End Date

Revised Obligation Download

Revised Settlement Date








Additional Points:


  • Demat shares should be delivered only through the Early Pay-in of Shares mechanism, which is available in both the depositories. In addition to the other details, the Market Type “(Buyback)” and settlement No.2021045 are to be used by Members/Custodians in the depository system.
  • Members/Custodians are requested to refer to Notice No.20200528-32 dated May 28, 2020 regarding settlement as per Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange.


Members are requested to refer MBRSTD_OTB_CM_mmm_SettNo file for client wise Stamp Duty charges.


For any further clarifications, Members & Custodians may contact their relationship managers or BSE Help Desk:-

Name of Official

Contact Number

Email ID

BSE Help Desk



For Indian Clearing Corporation Ltd.

Sanjay Narvankar                                                                             Ajay Darji

ADGM                                                                                                  Dy. Gen. Manager


May 17, 2021